# Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies

> **NCT05573724** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16 (actual)

## Conditions studied

- Advanced Solid Malignancies

## Interventions

- **DRUG:** AZD5305
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT05573724
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-07
- **Primary completion:** 2023-04-17
- **Final completion:** 2024-05-17
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05573724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05573724, "Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05573724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*